McNeil Consumer Healthcare Looks to Begin PR Work on Tylenol Line of Product

McNeil Consumer Healthcare, a subsidy of Johnson & Johnson, recently announced that the company has issued "an RFP for consumer PR work for its Tylenol franchise," according to PR Week.

While the pharmaceutical company is in the early stages of the RFP, Barbara Montresor, VP of corporate communications at McNeil Consumer Healthcare, said they are discussing aspects of the Tylenol business with agency partners.

McNeil Consumer Healthcare, located in Fort Washington, produces the Johnson & Johnson Tylenol line of products, which had a major recall of the entire infant product line earlier this year.

Additionally, the Huffington Post reported in April that products such as Infants' Tylenol, Pepcid Complete, eight-hour Tylenol and Simply Sleep may become unavailable on store shelves until 2013 while the company resolves manufacturing issues.

Manufacturing deficiencies at McNeil plants were cited in the 2011 governmental legal action against McNeil Consumer Healthcare as the reason for the recalls.